Floatz logo

Therapeutic Asset Ratings

3,272 results matching 1 filter

91,564 assets · 7,904 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
FLUDEOXYGLUCOSE
Anal Margin Squamous Cell Carcinoma
National Cancer Institute (NCI)P2CCC (53)
FLUDEOXYGLUCOSE
Anal Squamous Cell Carcinoma
National Cancer Institute (NCI)P2CCC (53)
FLUDEOXYGLUCOSE
HIV Infectious Disease
National Cancer Institute (NCI)P2CCC (53)
FLUDEOXYGLUCOSE
Nodular Lymphocyte Predominant Hodgkin Lymphoma
National Cancer Institute (NCI)P2CCC (53)
FLUDEOXYGLUCOSE
Pheochromocytoma-Paraganglioma
National Cancer Institute (NCI)P2CCC (53)
FLUDEOXYGLUCOSE
Squamous Cell Carcinoma Of Rectum
National Cancer Institute (NCI)P2CCC (53)
FLUOROURACILUM
Anal Margin Squamous Cell Carcinoma
National Cancer Institute (NCI)P2CCC (53)
FLUOROURACILUM
Female Reproductive Organ Cancer
National Cancer Institute (NCI)P2CCC (53)
FLUOROURACILUM
Her2-Receptor Negative Breast Cancer
National Cancer Institute (NCI)P2CCC (53)
FLUOROURACILUM
Squamous Cell Carcinoma Of Rectum
National Cancer Institute (NCI)P2CCC (53)
FLUOROURACILUM
Fallopian Tube Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Gemtuzumab Ozogamicin
Acute Myeloid Leukemia With Multilineage Dysplasia
National Cancer Institute (NCI)P2CCC (53)
Gemtuzumab Ozogamicin
Acute Megakaryoblastic Leukemia In Adult
National Cancer Institute (NCI)P2CCC (53)
Gemtuzumab Ozogamicin
Acute Myeloid Leukemia By FAB Classification
National Cancer Institute (NCI)P2CCC (53)
Gemtuzumab Ozogamicin
Core Binding Factor Acute Myeloid Leukemia
National Cancer Institute (NCI)P2CCC (53)
Gilteritinib
Acute Myeloid Leukemia With Multilineage Dysplasia
National Cancer Institute (NCI)P2CCC (53)
Gilteritinib
Therapy Related Acute Myeloid Leukemia And Myelodysplastic Syndrome
National Cancer Institute (NCI)P2CCC (53)
Gsk-2636771
Lymphoma
National Cancer Institute (NCI)P2CCC (53)
Gsk-2636771
Urinary Bladder Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Gsk-2636771
Breast Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Gsk-2636771
Cervical Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Gsk-2636771
Colon Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Gsk-2636771
Endometrial Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Gsk-2636771
Carcinoma Of Esophagus
National Cancer Institute (NCI)P2CCC (53)
Gsk-2636771
Exocrine Pancreatic Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Showing 1376 to 1400 of 3,272 assets
PreviousPage 56 of 131Next